Back to top
more

AMN Healthcare Services (AMN)

(Real Time Quote from BATS)

$17.10 USD

17.10
273,001

-0.39 (-2.23%)

Updated Aug 6, 2025 11:30 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (73 out of 246)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Medtronic (MDT) Sees Business Recovery Despite Volume Pressure

by Zacks Equity Research

According to Medtronic (MDT), healthcare systems are better prepared as vaccination rates continue to increase.

Zacks Equity Research

Here's Why You Should Retain ResMed (RMD) Stock for Now

by Zacks Equity Research

Investors are optimistic about ResMed (RMD) owing to new product launches in the SDB market and strong sales of mask products.

Zacks Equity Research

Here's Why You Should Add DexCom (DXCM) Stock to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about DexCom (DXCM) owing to its slew of favorable coverage decisions for its G6 CGM System.

Zacks Equity Research

Here is Why Growth Investors Should Buy AMN Healthcare (AMN) Now

by Zacks Equity Research

AMN Healthcare (AMN) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

AMN vs. AMEH: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

AMN vs. AMEH: Which Stock Is the Better Value Option?

Zacks Equity Research

Abbott (ABT) Gets FDA Nod for Amplatzer Talisman System

by Zacks Equity Research

The Amplatzer Talisman PFO Occlusion System from Abbott (ABT) is used to treat patients with a patent foramen ovale and are at risk of recurrent ischemic stroke.

Zacks Equity Research

AMN Healthcare (AMN) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

AMN Healthcare (AMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

AMN Healthcare (AMN) Hits 52-Week High: What's Behind It?

by Zacks Equity Research

Investors are optimistic about AMN Healthcare's (AMN) broad array of services.

Zacks Equity Research

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Zacks Equity Research

Reasons to Hold on to AMN Healthcare (AMN) Stock for Now

by Zacks Equity Research

Investors remain optimistic about AMN Healthcare (AMN) on its broad array of services.

Zacks Equity Research

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Zacks Equity Research

AMN Healthcare (AMN) Hits 52-Week High: What's Behind It?

by Zacks Equity Research

Investors are optimistic about AMN Healthcare's (AMN) broad array of services.

Zacks Equity Research

Is AMN Healthcare Services (AMN) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (AMN) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

AMN Healthcare (AMN) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

AMN Healthcare (AMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

AMN Healthcare (AMN) Q2 Earnings Beat Estimates, Margins Up

by Zacks Equity Research

AMN Healthcare's (AMN) robust Q2 results demonstrate its segmental strength.

Zacks Equity Research

AMN Healthcare Services (AMN) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

AMN Healthcare (AMN) delivered earnings and revenue surprises of 11.56% and 3.39%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

AMN Healthcare (AMN) to Report Q2 Earnings: What to Expect?

by Zacks Equity Research

Continued strength in AMN Healthcare's (AMN) staffing services is expected to have driven up Q2 sales.

Zacks Equity Research

AMN Healthcare Services (AMN) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Exact Sciences (EXAS) Q2 Loss Wider Than Expected, Revenues Top

by Zacks Equity Research

Exact Sciences' (EXAS) legacy Screening business sees significant improvement in revenues during the second quarter on Cologuard volume growth.

Zacks Equity Research

LabCorp (LH) Q2 Earnings Surpass Estimates, 2021 View Raised

by Zacks Equity Research

LabCorp (LH) Diagnostics revenues in the second quarter increase significantly on organic Base Business volume improvements despite decelerating demand for COVID-19 testing.

Zacks Equity Research

CONMED's (CNMD) Q2 Earnings Surpass Estimates, '21 View Up

by Zacks Equity Research

CONMED (CNMD) witnesses revenue uptick in both of its segments during Q2 despite continued pandemic-led business disruptions.

Zacks Equity Research

NuVasive (NUVA) Q2 Earnings Beat Estimates, Gross Margin Up

by Zacks Equity Research

NuVasive (NUVA) reports strong segmental and geographical performance driving the top line in second-quarter 2021.

Zacks Equity Research

Baxter (BAX) Q2 Earnings Surpass Estimates, Revenues Miss

by Zacks Equity Research

Baxter's (BAX) second-quarter results reflect robust performance across all its business units.

Zacks Equity Research

West Pharmaceutical (WST) Q2 Earnings & Revenues Top Estimates

by Zacks Equity Research

West Pharmaceutical's (WST) second-quarter earnings reflect strong segmental performance.

Zacks Equity Research

Integra (IART) Q2 Earnings Top Estimates, 2021 Guidance Up

by Zacks Equity Research

Integra (IART) reports better-than-expected revenues with strong segmental performance driving the top line in second-quarter 2021.